Skip to content
10-Q

Quarterly Report

Rain Oncology Inc.

0001558370-23-018562

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 3, 2023 36.38M sh
Shares Diluted Q3 2023 · Sep 30, 2023 36.38M sh
Shares Diluted Q3 2023 · Sep 30, 2023 36.36M sh
Shares Diluted Q3 2023 · Sep 30, 2022 26.56M sh
Shares Diluted Q3 2023 · Sep 30, 2022 26.54M sh
Capex Q3 2023 · Sep 30, 2023 $684K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$52.46M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$49.91M
Short Term Investments Q3 2023 · Sep 30, 2023 $40.01M
Short Term Investments Q3 2023 · Dec 31, 2022 $68.5M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $37.31M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $61.96M
Stockholders Equity Q3 2023 · Sep 30, 2023 $67.52M
Stockholders Equity Q3 2023 · Jun 30, 2023 $73.29M
Stockholders Equity Q3 2023 · Mar 31, 2023 $94.56M
Stockholders Equity Q3 2023 · Dec 31, 2022 $113.04M
Stockholders Equity Q3 2023 · Sep 30, 2022 $81.41M
Stockholders Equity Q3 2023 · Jun 30, 2022 $98.29M
Stockholders Equity Q3 2023 · Mar 31, 2022 $114.45M
Stockholders Equity Q3 2023 · Dec 31, 2021 $130.5M
Current Liabilities Q3 2023 · Sep 30, 2023 $14.48M
Current Liabilities Q3 2023 · Dec 31, 2022 $21.97M
Total Liabilities Q3 2023 · Sep 30, 2023 $14.54M
Total Liabilities Q3 2023 · Dec 31, 2022 $22.14M
Current Assets Q3 2023 · Sep 30, 2023 $80.82M
Current Assets Q3 2023 · Dec 31, 2022 $133.63M
Total Assets Q3 2023 · Sep 30, 2023 $82.06M
Total Assets Q3 2023 · Dec 31, 2022 $135.18M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.19
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.36
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.68
Eps Diluted Q3 2023 · Sep 30, 2022 −$2.00
Eps Basic Q3 2023 · Sep 30, 2023 −$0.19
Eps Basic Q3 2023 · Sep 30, 2023 −$1.36
Eps Basic Q3 2023 · Sep 30, 2022 −$0.68
Eps Basic Q3 2023 · Sep 30, 2022 −$2.00
Sga Expense Q3 2023 · Sep 30, 2023 $4.11M
Sga Expense Q3 2023 · Sep 30, 2023 $14.59M
Sga Expense Q3 2023 · Sep 30, 2022 $3.9M
Sga Expense Q3 2023 · Sep 30, 2022 $11.26M
Rd Expense Q3 2023 · Sep 30, 2023 $3.97M
Rd Expense Q3 2023 · Sep 30, 2023 $35.62M
Rd Expense Q3 2023 · Sep 30, 2022 $14.51M
Rd Expense Q3 2023 · Sep 30, 2022 $42.32M
Net Income Q3 2023 · Sep 30, 2023 −$7.03M
Net Income Q3 2023 · Sep 30, 2023 −$49.58M
Net Income Q3 2023 · Jun 30, 2023 −$22.06M
Net Income Q3 2023 · Mar 31, 2023 −$20.48M
Net Income Q3 2023 · Sep 30, 2022 −$18.04M
Net Income Q3 2023 · Sep 30, 2022 −$53.05M
Net Income Q3 2023 · Jun 30, 2022 −$17.61M
Net Income Q3 2023 · Mar 31, 2022 −$17.39M
Operating Income Q3 2023 · Sep 30, 2023 −$8.08M
Operating Income Q3 2023 · Sep 30, 2023 −$53.05M
Operating Income Q3 2023 · Sep 30, 2022 −$18.41M
Operating Income Q3 2023 · Sep 30, 2022 −$53.58M